{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:41:35Z","timestamp":1787503295916,"version":"build-2736575974"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Session 3 of the 2021 Workshop of the Society for Hematopathology\/European Association for Haematopathology examined progression and transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL) and B-cell prolymphocytic leukemia (B-PLL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-one cases were reviewed by the panel. Additional studies such as immunohistochemistry and molecular genetic testing, including whole-exome sequencing and expression profiling, were performed in select cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Session 3 included 27 CLL\/SLL cases and miscellaneous associated proliferations, 3 cases of B-PLL, and 1 case of small B-cell lymphoma. The criteria for \u00adaccelerated CLL\/SLL are established for lymph nodes, but extranodal disease can be diagnostically challenging. Richter transformation (RT) is a broad term and includes true transformation from original CLL\/SLL clone(s) and clonally unrelated neoplasms. The morphologic, immunophenotypic, and genetic spectrum is diverse with classical and highly unusual examples. T-cell proliferations can also be encountered in CLL\/SLL. B-cell prolymphocytic leukemia is a rare, diagnostically challenging disease due to its overlaps with other lymphoid neoplasms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The workshop highlighted complexity of progression and transformation in CLL\/SLL and B-PLL, as well as diagnostic caveats accompanying heterogeneous presentations of RT and other manifestations of disease progression. Molecular genetic studies are pivotal for diagnosis and determination of clonal relationship, and to predict response to treatment and identify resistance to targeted therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqad027","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T09:44:59Z","timestamp":1677923099000},"page":"554-571","source":"Crossref","is-referenced-by-count":8,"title":["Progression and transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH\/EAHP Workshop"],"prefix":"10.1093","volume":"159","author":[{"given":"Magdalena","family":"Czader","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine , Indianapolis, IN , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Amador","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine , Miami, FL , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-8085","authenticated-orcid":false,"given":"James R","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Cleveland Clinic , Cleveland, OH , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devang","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine , Durham, NC , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay","family":"Parker","sequence":"additional","affiliation":[{"name":"Data Driven Bioscience , Durham, NC , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep S","family":"Dave","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine , Durham, NC , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S","family":"Duffield","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai Hospital , New York, NY , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nejati","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fox Chase Cancer Center , Philadelphia, PA , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology , Stuttgart , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-8500","authenticated-orcid":false,"given":"Wenbin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-8517","authenticated-orcid":false,"given":"Mariusz","family":"Wasik","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fox Chase Cancer Center , Philadelphia, PA , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Goodlad","sequence":"additional","affiliation":[{"name":"NHS Greater Glasgow and Clyde , Glasgow , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"2023060108053045500_CIT0001","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2352-3026(17)30232-6","article-title":"Epidemiological patterns of leukaemia in 184 countries: a population-based study","volume":"5","author":"Miranda-Filho","year":"2018","journal-title":"Lancet Haematol"},{"key":"2023060108053045500_CIT0002"},{"key":"2023060108053045500_CIT0003","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41375-020-01057-5","article-title":"Ethnic and geographic diversity of chronic lymphocytic leukaemia","volume":"35","author":"Yang","year":"2021","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0004","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2017-11-814608","article-title":"Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis","volume":"131","author":"Kleinstern","year":"2018","journal-title":"Blood."},{"key":"2023060108053045500_CIT0005","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1080\/10428194.2017.1397660","article-title":"The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia","volume":"59","author":"Martinez-Trillos","year":"2018","journal-title":"Leuk Lymphoma."},{"key":"2023060108053045500_CIT0006","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood."},{"key":"2023060108053045500_CIT0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann Oncol."},{"key":"2023060108053045500_CIT0008","author":"National Comprehensive Cancer Network."},{"key":"2023060108053045500_CIT0009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/PPO.0000000000000538","article-title":"Genetics of chronic lymphocytic leukemia","volume":"27","author":"Bosch","year":"2021","journal-title":"Cancer J"},{"key":"2023060108053045500_CIT0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"Duhren-von Minden","year":"2012","journal-title":"Nature."},{"key":"2023060108053045500_CIT0011","doi-asserted-by":"crossref","first-page":"15746","DOI":"10.1038\/ncomms15746","article-title":"Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia","volume":"8","author":"Minici","year":"2017","journal-title":"Nat Commun."},{"key":"2023060108053045500_CIT0012","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2020007039","article-title":"Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL","volume":"137","author":"Agathangelidis","year":"2021","journal-title":"Blood."},{"key":"2023060108053045500_CIT0013","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/leu.2016.322","article-title":"Antigen receptor stereotypy in chronic lymphocytic leukemia","volume":"31","author":"Stamatopoulos","year":"2017","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0014","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-14-0630","article-title":"Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution","volume":"74","author":"Vardi","year":"2014","journal-title":"Cancer Res."},{"key":"2023060108053045500_CIT0015","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41375-022-01604-2","article-title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL","volume":"36","author":"Agathangelidis","year":"2022","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0016","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.5858\/arpa.2020-0654-OA","article-title":"A tissue counterpart to monoclonal B-cell lymphocytosis","volume":"145","author":"Habermehl","year":"2021","journal-title":"Arch Pathol Lab Med."},{"key":"2023060108053045500_CIT0017","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V100.2.635","article-title":"Monoclonal B lymphocytes with the characteristics of \u201cindolent\u201d chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood."},{"key":"2023060108053045500_CIT0018","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","article-title":"Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly","volume":"103","author":"Ghia","year":"2004","journal-title":"Blood."},{"key":"2023060108053045500_CIT0019","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2141.2007.06870.x","article-title":"Monoclonal B-cell lymphocytosis in blood donors","volume":"139","author":"Rachel","year":"2007","journal-title":"Br J Haematol."},{"key":"2023060108053045500_CIT0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2009-01-197368","article-title":"Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach","volume":"114","author":"Nieto","year":"2009","journal-title":"Blood."},{"key":"2023060108053045500_CIT0021","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3026(16)30192-2","article-title":"Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study","volume":"4","author":"Rawstron","year":"2017","journal-title":"Lancet Haematol"},{"key":"2023060108053045500_CIT0022","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.3324\/haematol.2019.230813","article-title":"High frequency of chronic lymphocytic leukemia-like low-count monoclonal B-cell lymphocytosis in Japanese descendants living in Brazil","volume":"105","author":"de Faria-Moss","year":"2020","journal-title":"Haematologica."},{"key":"2023060108053045500_CIT0023","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3324\/haematol.2017.177212","article-title":"Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations","volume":"103","author":"Agathangelidis","year":"2018","journal-title":"Haematologica."},{"key":"2023060108053045500_CIT0024","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMoa0806122","article-title":"B-cell clones as early markers for chronic lymphocytic leukemia","volume":"360","author":"Landgren","year":"2009","journal-title":"N Engl J Med."},{"key":"2023060108053045500_CIT0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","article-title":"Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia","volume":"359","author":"Rawstron","year":"2008","journal-title":"N Engl J Med."},{"key":"2023060108053045500_CIT0026","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3324\/haematol.2017.183954","article-title":"Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome","volume":"103","author":"Criado","year":"2018","journal-title":"Haematologica."},{"key":"2023060108053045500_CIT0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.2020009813","article-title":"The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL","volume":"138","author":"Parikh","year":"2021","journal-title":"Blood."},{"key":"2023060108053045500_CIT0028","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","article-title":"General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL","volume":"118","author":"Fazi","year":"2011","journal-title":"Blood."},{"key":"2023060108053045500_CIT0029","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","article-title":"Growth dynamics in naturally progressing chronic lymphocytic leukaemia","volume":"570","author":"Gruber","year":"2019","journal-title":"Nature."},{"key":"2023060108053045500_CIT0030","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-017-02329-y","article-title":"The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy","volume":"8","author":"Landau","year":"2017","journal-title":"Nat Commun."},{"key":"2023060108053045500_CIT0031","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood."},{"key":"2023060108053045500_CIT0032","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMc1402716","article-title":"Ibrutinib resistance in chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N Engl J Med."},{"key":"2023060108053045500_CIT0033","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/2159-8290.CD-18-1119","article-title":"Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia","volume":"9","author":"Blombery","year":"2019","journal-title":"Cancer Discov"},{"key":"2023060108053045500_CIT0034","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-97187-7","volume-title":"Histopathology of Non-Hodgkin\u2019s Lymphomas (Based on the Updated Kiel Classification)","author":"Lennert","year":"1992"},{"key":"2023060108053045500_CIT0035","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","article-title":"Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\u201caccelerated\u201d chronic lymphocytic leukemia) with aggressive clinical behavior","volume":"95","author":"Gine","year":"2010","journal-title":"Haematologica."},{"key":"2023060108053045500_CIT0036","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/leu.2011.247","article-title":"Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays","volume":"26","author":"Ciccone","year":"2012","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0037","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2013-11-536169","article-title":"Correlation between FDG\/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia","volume":"123","author":"Falchi","year":"2014","journal-title":"Blood."},{"key":"2023060108053045500_CIT0038","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13024","article-title":"Diagnostic dilemmas of high-grade transformation (Richter\u2019s syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review","volume":"69","author":"Soilleux","year":"2016","journal-title":"Histopathology."},{"key":"2023060108053045500_CIT0039","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41379-022-01015-9","article-title":"Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia","volume":"35","author":"El Hussein","year":"2022","journal-title":"Mod Pathol."},{"key":"2023060108053045500_CIT0040","article-title":"Chronic lymphocytic leukemia progression diagnosis with intrinsic cellular patterns via unsupervised clustering","volume":"14","author":"Chen","year":"13 2022","journal-title":"Cancers (Basel)"},{"key":"2023060108053045500_CIT0041","first-page":"216","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Campo","year":"2017"},{"key":"2023060108053045500_CIT0042","volume-title":"WHO Classification of Hematolymphoid Tumours","author":"World Health Organization.","year":"2022","edition":"5"},{"key":"2023060108053045500_CIT0043","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bjh.14132","article-title":"The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic\/molecular markers in the LRF CLL4 trial","volume":"174","author":"Oscier","year":"2016","journal-title":"Br J Haematol."},{"key":"2023060108053045500_CIT0044","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1200\/JCO.22.01028","article-title":"Emerging therapies for the management of Richter transformation","volume":"41","author":"Smyth","year":"2023","journal-title":"J Clin Oncol"},{"key":"2023060108053045500_CIT0045","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00277-021-04603-y","article-title":"Outcomes of Richter\u2019s transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL): an analysis of the SEER database","volume":"100","author":"Elnair","year":"2021","journal-title":"Ann Hematol."},{"key":"2023060108053045500_CIT0046","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41375-020-0797-x","article-title":"Richter transformation in chronic lymphocytic leukemia (CLL)\u2014a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials","volume":"35","author":"Al-Sawaf","year":"2021","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0047","doi-asserted-by":"crossref","first-page":"100824","DOI":"10.1016\/j.blre.2021.100824","article-title":"Revisiting Richter transformation in the era of novel CLL agents","volume":"49","author":"Petrackova","year":"2021","journal-title":"Blood Rev."},{"key":"2023060108053045500_CIT0048","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ajh.24566","article-title":"PET-positive lymphadenopathy in CLL\u2014not always Richter transformation","volume":"92","author":"Pemmaraju","year":"2017","journal-title":"Am J Hematol."},{"key":"2023060108053045500_CIT0049","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hon.2222","article-title":"XIV. The pathology of transformation of indolent B cell lymphomas","volume":"33","author":"Gascoyne","year":"2015","journal-title":"Hematol Oncol."},{"key":"2023060108053045500_CIT0050","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/17474086.2016.1199948","article-title":"Richter transformation of CLL","volume":"9","author":"Jain","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"2023060108053045500_CIT0051","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","article-title":"Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis\u2014with comparison to Hodgkin-like lesion","volume":"55","author":"Xiao","year":"2016","journal-title":"Hum Pathol."},{"key":"2023060108053045500_CIT0052","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.2019.224121","article-title":"Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica."},{"key":"2023060108053045500_CIT0053","first-page":"348","article-title":"Richter transformation of chronic lymphocytic leukemia in the era of novel agents","volume":"18","author":"Wang","year":"2020","journal-title":"Clin Adv Hematol Oncol."},{"key":"2023060108053045500_CIT0054","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2018-01-791376","article-title":"Biology and treatment of Richter syndrome","volume":"131","author":"Rossi","year":"2018","journal-title":"Blood."},{"key":"2023060108053045500_CIT0055","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med."},{"key":"2023060108053045500_CIT0056","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.2020005650","article-title":"Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia","volume":"137","author":"Klintman","year":"2021","journal-title":"Blood."},{"key":"2023060108053045500_CIT0057","doi-asserted-by":"crossref","first-page":"IJH09","DOI":"10.2217\/ijh-2018-0010","article-title":"Current trends in the management of Richter\u2019s syndrome","volume":"7","author":"Allan","year":"2018","journal-title":"Int J Hematol Oncol"},{"key":"2023060108053045500_CIT0058","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/bjh.18352","article-title":"Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome","volume":"198","author":"Favini","year":"2022","journal-title":"Br J Haematol."},{"key":"2023060108053045500_CIT0059","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.1999.01549.x","article-title":"Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukaemia to non-Hodgkin\u2019s lymphoma","volume":"106","author":"Qian","year":"1999","journal-title":"Br J Haematol."},{"key":"2023060108053045500_CIT0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1634\/theoncologist.2020-0388","article-title":"Disease flare during temporary interruption of ibrutinib therapy in patients with chronic lymphocytic leukemia","volume":"25","author":"Hampel","year":"2020","journal-title":"Oncologist"},{"key":"2023060108053045500_CIT0061","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/bloodadvances.2020002454","article-title":"Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib","volume":"4","author":"Hampel","year":"2020","journal-title":"Blood Adv."},{"key":"2023060108053045500_CIT0062","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/bjh.16948","article-title":"Pseudo-Richter transformation of chronic lymphocytic leukaemia\/small lymphocytic lymphoma following ibrutinib interruption: a diagnostic pitfall","volume":"191","author":"Barnea Slonim","year":"2020","journal-title":"Br J Haematol."},{"key":"2023060108053045500_CIT0063","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.5060","article-title":"Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia","volume":"245","author":"Garcia-Barchino","year":"2018","journal-title":"J Pathol."},{"key":"2023060108053045500_CIT0064","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter\u2019s transformation diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"2023060108053045500_CIT0065","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.3390\/cancers13205141","article-title":"Richter transformation in chronic lymphocytic leukemia: update in the era of novel agents","volume":"13","author":"Tadmor","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2023060108053045500_CIT0066","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41408-022-00616-6","article-title":"Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs classic Hodgkin lymphoma transformation of CLL: does this distinction matter?","volume":"12","author":"King","year":"2022","journal-title":"Blood Cancer J."},{"key":"2023060108053045500_CIT0067","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.3324\/haematol.2020.256388","article-title":"Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration","volume":"106","author":"Stephens","year":"2021","journal-title":"Haematologica."},{"key":"2023060108053045500_CIT0068","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/his.13885","article-title":"The t(11;14)(q13;q32)\/CCND1-IGH translocation in chronic lymphocytic leukaemia\/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course","volume":"75","author":"Liu","year":"2019","journal-title":"Histopathology."},{"key":"2023060108053045500_CIT0069","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3109\/10428194.2016.1153085","article-title":"The t(11;14)(q13;q32)\/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia","volume":"57","author":"Schliemann","year":"2016","journal-title":"Leukemia Lymphoma."},{"key":"2023060108053045500_CIT0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med."},{"key":"2023060108053045500_CIT0071","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3109\/10428194.2012.676172","article-title":"Richter transformation of chronic lymphocytic leukemia into composite diffuse large B-cell and Hodgkin lymphoma","volume":"53","author":"Michelis","year":"2012","journal-title":"Leukemia Lymphoma"},{"key":"2023060108053045500_CIT0072","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000505683","article-title":"Chronic lymphocytic leukemia with divergent Richter\u2019s transformation into a clonally related classical Hodgkin\u2019s and plasmablastic lymphoma: a case report","volume":"13","author":"Gasljevic","year":"2020","journal-title":"Case Rep Oncol"},{"key":"2023060108053045500_CIT0073","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","article-title":"Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases","volume":"37","author":"Martinez","year":"2013","journal-title":"Am J Surg Pathol."},{"key":"2023060108053045500_CIT0074","first-page":"2861596","article-title":"Plasmablastic lymphoma with coexistence of chronic lymphocytic leukemia in an immunocompetent patient: a case report and mini-review","volume":"2017","author":"Hatzimichael","year":"2017","journal-title":"Case Rep Hematol"},{"key":"2023060108053045500_CIT0075","first-page":"242","article-title":"Ileal plasmablastic lymphoma presenting as intestinal occlusion in an HIV-negative patient with chronic lymphocytic leukemia","volume":"114","author":"Figuero-Perez","year":"2022","journal-title":"Rev Esp Enferm Dig."},{"key":"2023060108053045500_CIT0076","doi-asserted-by":"crossref","first-page":"e235816","DOI":"10.1136\/bcr-2020-235816","article-title":"Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment","volume":"13","author":"Marvyin","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2023060108053045500_CIT0077","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood."},{"key":"2023060108053045500_CIT0078","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.mpdhp.2020.06.005","article-title":"Burkitt-like lymphoma with 11q aberration","volume":"26","author":"Westwood","year":"2020","journal-title":"Diagnostic Histopathol"},{"key":"2023060108053045500_CIT0079","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.prp.2016.09.013","article-title":"B-lymphoblastic leukemia in a patient with chronic lymphocytic leukemia: sequential development of biclonal B-cell neoplasms over a 23-year period in a single individual","volume":"212","author":"Wu","year":"2016","journal-title":"Pathol Res Pract."},{"key":"2023060108053045500_CIT0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1309\/AJCPXE5VMONMVLZ0","article-title":"B-lymphoblastic leukemia in patients with chronic lymphocytic leukemia: a report of four cases","volume":"144","author":"Chakhachiro","year":"2015","journal-title":"Am J Clin Pathol."},{"key":"2023060108053045500_CIT0081","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/bjh.17008","article-title":"Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring","volume":"191","author":"Derrieux","year":"2020","journal-title":"Br J Haematol."},{"key":"2023060108053045500_CIT0082","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cancergencyto.2008.10.003","article-title":"Inactivation of p53 and amplification of MYCN gene in a terminal lymphoblastic relapse in a chronic lymphocytic leukemia patient","volume":"189","author":"Stano-Kozubik","year":"2009","journal-title":"Cancer Genet Cytogenet."},{"key":"2023060108053045500_CIT0083","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2017-11-819276","article-title":"Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia","volume":"131","author":"Yun","year":"2018","journal-title":"Blood."},{"key":"2023060108053045500_CIT0084","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature21406","article-title":"Phosphatidylinositol 3-kinase delta blockade increases genomic instability in B cells","volume":"542","author":"Compagno","year":"2017","journal-title":"Nature."},{"key":"2023060108053045500_CIT0085","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41375-020-0873-2","article-title":"T-cells in chronic lymphocytic leukemia: guardians or drivers of disease?","volume":"34","author":"Roessner","year":"2020","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0086","doi-asserted-by":"crossref","first-page":"612244","DOI":"10.3389\/fimmu.2020.612244","article-title":"T cells in chronic lymphocytic leukemia: a two-edged sword","volume":"11","author":"Vlachonikola","year":"2020","journal-title":"Front Immunol."},{"key":"2023060108053045500_CIT0087","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/leu.2016.362","article-title":"Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements","volume":"31","author":"Vardi","year":"2017","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0088","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0320(20000615)42:3<188::AID-CYTO5>3.0.CO;2-Q","article-title":"Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population","volume":"42","author":"Goolsby","year":"2000","journal-title":"Cytometry."},{"key":"2023060108053045500_CIT0089","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0000000000001646","article-title":"Angioimmunoblastic T-cell lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a novel form of composite lymphoma potentially mimicking Richter syndrome","volume":"45","author":"Trimech","year":"2021","journal-title":"Am J Surg Pathol."},{"key":"2023060108053045500_CIT0090","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ijd.13653","article-title":"Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma","volume":"56","author":"Chang","year":"2017","journal-title":"Int J Dermatol."},{"key":"2023060108053045500_CIT0091","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/10428194.2014.927460","article-title":"Development of T-cell lymphomas with an activated cytotoxic immunophenotype, including anaplastic large cell lymphomas, in patients with chronic lymphocytic leukemia: a series of six cases","volume":"56","author":"Mant","year":"2015","journal-title":"Leukemia Lymphoma."},{"key":"2023060108053045500_CIT0092","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PAS.0000000000000140","article-title":"Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"38","author":"Boyer","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"2023060108053045500_CIT0093","first-page":"222","article-title":"B-cell prolymphocytic leukemia.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Campo","year":"2017"},{"key":"2023060108053045500_CIT0094","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/leu.2009.137","article-title":"B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures","volume":"23","author":"Del Giudice","year":"2009","journal-title":"Leukemia."},{"key":"2023060108053045500_CIT0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood-2013-10-533869","article-title":"B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma","volume":"124","author":"van der Velden","year":"2014","journal-title":"Blood."},{"key":"2023060108053045500_CIT0096","first-page":"1821","article-title":"Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53","volume":"134","author":"Chapiro","year":"2019","journal-title":"Blood."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/159\/6\/554\/50493399\/aqad027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/159\/6\/554\/50493399\/aqad027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T04:11:36Z","timestamp":1685592696000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/159\/6\/554\/7117556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":96,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,4,13]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqad027","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2023,4,13]]}}}